Profile of Drug-Resistant Tuberculosis Patients at Rumah Sakit Universitas Indonesia Depok Period October 2024
DOI:
https://doi.org/10.59188/eduvest.v5i3.50269Keywords:
Drug-resistant, Linezolid, TuberculosisAbstract
Indonesia has been one of the three countries in Asia that contributes to the highest case of Tuberculosis (TB) in the world. Tuberculosis itself counted as the top ten cause of death globally. Two of the challenges in controlling TB cases are the occurrence of drug-resistance strain and patients’ adherence. Drug-resistant TB has to be treated with the second line drugs of TB with higher risk of adverse events. Linezolid as one of the suggested drugs by WHO in the treatment may increase patients’ risk of cytopenia events. This study was conducted to represent the profile of drug-resistant TB obtained from Rumah Sakit Universitas Indonesia (RSUI) Depok period October 2024. Design of this study is a quantitative-descriptive where the data of patients obtained from the patients’ medical records in the period of October 2024. The findings of this study showed the total number of drug-resistant TB was 104 with 3 cases of HIV and 70 patients having Linezolid in their regimen. Most of the patients are male with mean of age 41.3 years. New cases and RR/MDR TB level are dominated while on the other hand there’s 9 cases of After Failure and 4 others are After Loss to Follow-up. Median values obtained for patients’ leukocytes, hemoglobin, and platelets are 7818.0, 11.9, 279.5 respectively.
References
Adewole, P. D., Ogundipe, T. D., Alabi, O. S., & Nuhu, A. (2024). Haematological parameter among drug resistant tuberculosis patients in Ibadan. African Health Sciences, 24(1), 10–15.
Andriyanto, E., Subronto, Y. W., & Laksanawati, I. S. (2022). Predictor Factors of Tuberculosis Treatment Success in Sleman Regency of Indonesia: Predictor Factors of Tuberculosis Treatment Success in Sleman Regency of Indonesia. Medica Hospitalia: Journal of Clinical Medicine, 9(2), 187–193.
Bade, A. B., Mega, T. A., & Negera, G. Z. (2021). Malnutrition is associated with delayed sputum culture conversion among patients treated for MDR-TB. Infection and Drug Resistance, 1659–1667.
Chilyabanyama, R., Kamanga, N., & Mwandia, J. N. (2024). Factors associated with tuberculosis treatment outcomes among TB patients aged 15 years and older at chawama level one hospital in Lusaka, Zambia. Global Public Health, 19(1), 2307979.
Graciaa, D. S., Kipiani, M., Magee, M. J., Mikiashvili, L., Barbakadze, K., Bablishvili, N., Auld, S. C., Alghamdi, W. A., Alshaer, M. H., & Peloquin, C. A. (2022). Linezolid exposure is associated with cytopenias in patients treated for multidrug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy, 66(9), e00408-22.
Hase, I., Toren, K. G., Hirano, H., Sakurai, K., Horne, D. J., Saito, T., & Narita, M. (2021). Pulmonary tuberculosis in older adults: increased mortality related to tuberculosis within two months of treatment initiation. Drugs & Aging, 38, 807–815.
Humayun, M., Chirenda, J., Ye, W., Mukeredzi, I., Mujuru, H. A., & Yang, Z. (2022). Effect of gender on clinical presentation of tuberculosis (TB) and age-specific risk of TB, and TB-human immunodeficiency virus coinfection. Open Forum Infectious Diseases, 9(10), ofac512.
Krishna, S., & Jacob, J. J. (2021). Diabetes mellitus and tuberculosis.
Pradipta, I. (2020). Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program.
Pratama, N. Y. I., Zulkarnain, B. S., Soedarsono, & Fatmawati, U. (2021). Hematological side effect analysis of linezolid in MDR-TB patients with individual therapy. Journal of Basic and Clinical Physiology and Pharmacology, 32(4), 777–781.
Sayem, M. A., Hossain, M. G., Ahmed, T., Hossain, K., & Saud, Z. A. (2020). Effect of nutritional support on treatment of multi-drug resistant tuberculosis in Rajshahi Division, Bangladesh. Journal of Tuberculosis Research, 8(4), 223–236.
Smith, J. P., Gandhi, N. R., Shah, N. S., Mlisana, K., Moodley, P., Johnson, B. A., Allana, S., Campbell, A., Nelson, K. N., & Master, I. (2020). The impact of concurrent antiretroviral therapy and MDR-TB treatment on adverse events. JAIDS Journal of Acquired Immune Deficiency Syndromes, 83(1), 47–55.
Wagnew, F., Alene, K. A., Kelly, M., & Gray, D. (2023). The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis. International Journal of Infectious Diseases, 127, 93–105.
Wagnew, F., Alene, K. A., Kelly, M., & Gray, D. (2024). Impacts of body weight change on treatment outcomes in patients with multidrug-resistant tuberculosis in Northwest Ethiopia. Scientific Reports, 14(1), 508.
Xu, G., Hu, X., Lian, Y., & Li, X. (2023). Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), 813.
Ministry of Health. (2020). Management of Drug-Resistant Tuberculosis in Indonesia.
Ministry of Health. (2022). Report on the 2022 Tuberculosis Control Program.
Health, D. (n.d.). DEPOK CITY HEALTH PROFILE IN 2022 DEPOK CITY IN 2023. www.dinkes.depok.go.id
WHO. (2018). Tuberculosis In Women Factsheet.
WHO. (2022). Implementing The End Strategy TB 2022.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Suci Rizki Dumiarsih, Santi Purna Sari, Retnosari Andrajati, Diah Handayani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
